# Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure

> **NCT05940220** · PHASE3 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 130 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** Acetazolamide
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05940220
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-10-10
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05940220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05940220, "Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05940220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*